NorthWest Biotherapeutics Inc (NWBO)

[dmb2]

Doc logic, NWBO has forced hands here, it amazes me the differences in approach needed by a small startup vs a BP.

If a BP had such data in hand there would have been a much simpler approach and request from RA's to partner for the advancement of the science and in particular of the regulatory pathway, and the therapy would have come to market quicker. I know the BP offers the RA much more support info and resource but it is a shame to see such time expended at the expense of many current patients.

Truly better late than never,
GLTA